Today: 27 March 2026
CrowdStrike Stock Back in Focus as Cybersecurity Spending Holds Up, AI Debate Shifts

CrowdStrike Stock Back in Focus as Cybersecurity Spending Holds Up, AI Debate Shifts

New York, March 27, 2026, 09:30 EDT

CrowdStrike grabbed attention again Friday. Investors pointed to steady cybersecurity spending, plus another round of AI-related initiatives and partnerships, for keeping the name in the spotlight. The stock closed Thursday with a 1.75% gain at $392.62, still trailing its 52-week high by roughly 31%. MarketBeat

This matters because the company has spent the past several weeks squeezed between two stories: AI as a fresh catalyst for cybersecurity demand, or AI as a direct threat to existing software models. Back in February and March, Reuters reported that new tools from Anthropic sparked a broader slide in software shares. But Robert W. Baird’s Shrenik Kothari pushed back, labeling the move in cyber stocks “panic-driven, narrative-led”—not evidence that core real-time security platforms were actually being replaced. Reuters

Different angles on CrowdStrike’s prospects have surfaced in the past day. On Friday, MarketBeat pointed to the company’s dependence on rising annual recurring revenue—basically, those year-long subscription contracts—and its push to get customers to standardize on the Falcon platform. Over on Thursday, Seeking Alpha’s analysis argued that AI doesn’t pose an immediate risk to CrowdStrike’s main business. Meanwhile, Blockonomi, via MEXC, set up a comparison between CrowdStrike and Palo Alto Networks, casting it as a decision between chasing faster growth or sticking with stronger profitability now. MarketBeat

CrowdStrike looked to put its thesis into practice at the RSA Conference in San Francisco, rolling out Charlotte AI AgentWorks on March 25. The launch—done with partners AWS, Anthropic, OpenAI, Salesforce, and Nvidia—lets customers tap the Falcon platform to create and run security agents. “The future of security operations isn’t humans replaced by agents. It’s humans amplified by them,” chief business officer Daniel Bernard said. CrowdStrike

On the same day, IBM scored a new partner nod, deepening its alliance with CrowdStrike. The move brings CrowdStrike’s Charlotte AI together with IBM’s autonomous threat-ops platform. “Organizations are under pressure to accelerate response without increasing complexity,” said Dave McGinnis, IBM’s vice president for global managed security services. He pointed to continued demand for faster automation layered onto current security setups—rather than buyers opting for a total overhaul. CrowdStrike

Not much has shifted in the financial backdrop since March 3. CrowdStrike reported fiscal 2026 revenue up 22% at $4.81 billion, annual recurring revenue closing out at $5.25 billion, and free cash flow for the year at $1.24 billion. Founder and CEO George Kurtz pointed to AI’s role in positioning CrowdStrike as “mission-critical infrastructure.” Reuters noted the company’s outlook for fiscal 2027 revenue topped what Wall Street was expecting. CrowdStrike Holdings, Inc.

Rivals are moving, too. As MEXC pointed out, CrowdStrike is seeing faster growth, but Palo Alto stands out for size and margins. Reuters highlighted in February that Palo Alto bumped up its revenue forecast, though profit took a hit from added costs for AI and identity-security acquisitions. Last month, Reuters noted Zscaler’s earnings hinted at steadier cybersecurity budgets, even as broader IT spending showed more strain. MEXC

The narrative isn’t set in stone. CrowdStrike absorbed $117.7 million in fiscal 2026 costs after the July 2024 Windows outage, shares remain well under their November high, and February gave a sharp reminder: AI buzz can hit sector valuations fast, sometimes long before any actual revenue fallout is obvious. Reuters

The question with CrowdStrike isn’t whether businesses will stay hungry for cyber defense—it’s which platform comes out on top as the sector consolidates. Lately, the conversation has tipped back in CrowdStrike’s favor over the past couple of days, despite the stock’s chart not showing much relief. MarketBeat

Stock Market Today

  • Humacyte Q4 Loss Misses Revenue Estimates, Shares Down 19% in 2025
    March 27, 2026, 10:02 AM EDT. Humacyte, Inc. (HUMA) reported a Q4 loss of $0.13 per share, matching estimates but representing a 4% earnings surprise negatively, as revenue missed by over 70%, coming in at just $0.47 million vs. zero a year ago. Shares have dropped about 19% in 2025, lagging the S&P 500's 5.4% decline. The company's earnings outlook remains cautious with a Zacks Rank #3 (Hold), reflecting mixed estimate revisions ahead. Consensus sees a near-term EPS loss of $0.12 and revenues of $5.85 million next quarter. The broader Medical - Biomedical and Genetics industry ranks in the lower 40% of Zacks industries, dampening sentiment. Investors will likely focus on management's earnings call commentary to gauge sustainability of stock moves.
Snap Stock Price Slides After EU Child-Safety Probe Hits Snapchat Parent
Previous Story

Snap Stock Price Slides After EU Child-Safety Probe Hits Snapchat Parent

Go toTop